Related Experiment Video

Updated: Jul 14, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

[Topical and systemic corticosteroid therapy for uveitis in childhood]

S R Thurau1, M Frosch, M Zierhut

  • 1Augenklinik der Ludwig-Maximilians-Universität, München. Stephan.Thurau@med.uni-muenchen.de

Klinische Monatsblatter Fur Augenheilkunde
|June 28, 2007
PubMed

Insights

Corticosteroids are crucial for treating pediatric uveitis due to their fast action. Long-term use requires monitoring steroid levels to prevent growth retardation and considering early immunosuppressive therapy.

Area of Science:

  • Ophthalmology
  • Pediatric Endocrinology
  • Immunology

Context:

  • Uveitis in children necessitates prompt and effective treatment strategies.
  • Corticosteroids offer rapid therapeutic benefits for pediatric uveitis.
  • Topical and systemic corticosteroid administration is common in anterior uveitis management.

Purpose:

  • To highlight the role of corticosteroids in pediatric uveitis treatment.
  • To address the unique side effect profile in children, including growth retardation.
  • To emphasize the importance of managing steroid dosage and considering adjunctive immunosuppression for long-term therapy.

Summary:

  • Systemic and topical corticosteroids are vital for pediatric uveitis due to their rapid onset.
  • Treatment for anterior uveitis often involves frequent eye drop administration.
  • Children face risks of typical corticosteroid side effects plus growth retardation, necessitating careful management.

Impact:

  • Informs clinical practice regarding safe and effective corticosteroid use in pediatric uveitis.
  • Underscores the need for vigilance regarding systemic steroid exposure and potential long-term adverse effects.
  • Promotes early consideration of immunosuppressive agents to mitigate steroid-related complications and ensure optimal growth.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...